Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $37 million and $42 million during the three months ended April 3, 2026 and March 28, 2025, respectively. The activity during the three months ended April 3, 2026 and March 28, 2025 included $32 million and $30 million, respectively, of investments in alternative energy limited partnerships. Refer to Note 14 for additional information on these investments.

Proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $748 million during the three months ended March 28, 2025. In March 2025, the Company sold a portion of our ownership interest in Coca-Cola Europacific Partners plc (“CCEP”), an equity method investee, for which we received cash proceeds of $741 million and recognized a net gain of $331 million, which was recorded in the line item other income (loss) — net in our consolidated statement of income.

In October 2025, the Company entered into a definitive agreement to sell a portion of our interest in our bottling operations in Africa to Coca-Cola HBC AG (“CCHBC”), an equity method investee. Closing is subject to various regulatory approvals and is expected by the end of 2026, upon which we will deconsolidate these bottling operations. We have also agreed to a separate option arrangement for CCHBC to acquire the Company’s remaining 25% ownership interest within a six-year period from closing. As these operations met the criteria to be classified as held for sale, during the year ended December 31, 2025, we were required to record the related assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the estimated proceeds. This resulted in an impairment charge of $1,274 million, primarily due to the negative net foreign currency translation adjustments that will be reclassified to income upon sale. During the three months ended April 3, 2026, we recorded an additional impairment charge of $10 million based on management’s revised estimates. These charges were recorded in the line item other income (loss) — net in our consolidated statement of income.


	April 3, 2026		December 31, 2025
Cash, cash equivalents and short-term investments	$	172	$	178
Trade accounts receivable, less allowances	363		389
Inventories	436		466
Prepaid expenses and other current assets	161		147
Equity method investments	6		5
Deferred income tax assets	46		46
Property, plant and equipment — net	1,953		1,964
Trademarks with indefinite lives	2		2
Goodwill	3,284		3,350
Other noncurrent assets	64		60
Allowance for reduction of assets held for sale	(1,275)		(1,265)
Assets held for sale	$	5,212	$	5,342
Accounts payable and accrued expenses	$	668	$	816
Loans and notes payable	169		187
Current maturities of long-term debt	398		398
Accrued income taxes	35		5
Long-term debt	838		850
Other noncurrent liabilities	148		154
Deferred income tax liabilities	171		160
Liabilities held for sale	$	2,427	$	2,570